Loading...
•
Dec 31, 2022
Applied Therapeutics Q4 2022 Earnings Report
Reported financial results for the fourth quarter and full year ended December 31, 2022.
Key Takeaways
Applied Therapeutics reported financial results for the fourth quarter and full year ended December 31, 2022, highlighting clinical progress in Phase 3 programs and a deal with Advanz Pharma.
Clinical progress was made across all three registrational Phase 3 programs in 2022.
The company anticipates data readouts in the upcoming year.
A deal with Advanz Pharma demonstrated the ability to realize value in clinical programs.
The company is evaluating additional opportunities for value recognition.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...